KS

Karthikeyan Subhashri

Active Director Additional Director DIN 10536308
DIN 10536308 First appointment Mar 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Karthikeyan Subhashri

Data last updated:

Karthikeyan Subhashri is an Additional Director at Kasma Biotech Private Limited (since 2024). The company operates in Healthcare.

DIN 10536308
Primary Designation Additional Director
Industry Healthcare
First Appointment 07 Mar 2024
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kasma Biotech Private Limited U33100TZ2022PTC040053
Additional Director07 Mar 20242022Active

Board colleagues of Karthikeyan Subhashri

Directorship timeline

Open interactive timeline →
Kasma Biotech Private Limited
Premium access

Shareholding and investment profile for Karthikeyan Subhashri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Karthikeyan Subhashri

Karthikeyan Subhashri currently holds 1 directorship: Kasma Biotech Private Limited (Additional Director, since 07 Mar 2024).

Karthikeyan Subhashri was first appointed on 07 Mar 2024 as Additional Director at Kasma Biotech Private Limited.

The current boards of Karthikeyan Subhashri's companies include Karthi Keyan (Kasma Biotech Private Limited), Karthikeyan Srinath (Kasma Biotech Private Limited), Mohinudeen Sheriff (Kasma Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available